Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec;93(12):4804-9.
doi: 10.1210/jc.2008-0639. Epub 2008 Sep 16.

A bone structural basis for fracture risk in diabetes

L Joseph Melton 3rd  1 , B Lawrence Riggs, Cynthia L Leibson, Sara J Achenbach, Jon J Camp, Mary L Bouxsein, Elizabeth J Atkinson, Richard A Robb, Sundeep Khosla
Affiliations

A bone structural basis for fracture risk in diabetes

L Joseph Melton 3rd et al. J Clin Endocrinol Metab. 2008 Dec.

Abstract

Context: Elevated areal bone mineral density (aBMD) in type 2 diabetes mellitus is inconsistent with increased fracture risk at some skeletal sites.

Objectives: Because aBMD is an imperfect surrogate for bone strength, we assessed bone structure and strength more directly using quantitative computed tomography.

Design: Diabetic and nondiabetic subjects were evaluated in a cross-sectional study.

Setting: Subjects were recruited from a random sample of the Rochester, MN, population.

Participants: Forty-nine subjects (28 women and 21 men) with type 2 diabetes were compared with age- and sex-matched nondiabetic controls.

Main outcome measurements: We measured bone geometry, strength, and volumetric BMD (vBMD) at the hip, spine, and wrist, along with hip aBMD, using central and peripheral quantitative computed tomography and estimated bone load to bone strength ratios at each site.

Results: Adjusted for differences in body mass index between cases and controls (29.8 vs. 27.6), hip aBMD was greater in diabetic subjects, but this was accounted for by greater trabecular vBMD. Cortical vBMD was similar in the two groups, as was bone cross-sectional area and cortical thickness. Bone strength measures were generally better in diabetic subjects, but bone loads were higher from their greater weight. Consequently, load to strength ratios (i.e. factor-of-risk) were similar.

Conclusions: Patients with type 2 diabetes enjoy little benefit from elevated aBMD in terms of improved bone load to strength ratios. With no deficit in bone density, the rationale for antiresorptive therapy in diabetic patients is uncertain, but potential adverse effects of diabetes on bone quality need more study.

PubMed Disclaimer

References

    1. Janghorbani M, Van Dam RM, Willett WC, Hu FB 2007 Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505 - PubMed
    1. Heath III H, Melton III LJ, Chu CP 1980 Diabetes mellitus and risk of skeletal fracture. N Engl J Med 303:567–570 - PubMed
    1. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ, Blue Mountains Eye Study 2001 Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 24:1198–1203 - PubMed
    1. Forsen L, Meyer HE, Midthjell K, Edna TH 1999 Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42:920–925 - PubMed
    1. Leslie WD, Lix LM, Prior HJ, Derksen S, Metge C, O'Neil J 2007 Biphasic fracture risk in diabetes: a population-based study. Bone 40:1595–1601 - PubMed

Publication types